A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease.
Tzimopoulou
Sofia
S
GlaxoSmithKline Clinical Imaging Centre, Hammersmith Hospital, London, UK.
Cunningham
Vincent J
VJ
Nichols
Thomas E
TE
Searle
Graham
G
Bird
Nick P
NP
Mistry
Prafull
P
Dixon
Ian J
IJ
Hallett
William A
WA
Whitcher
Brandon
B
Brown
Andrew P
AP
Zvartau-Hind
Marina
M
Lotay
Narinder
N
Lai
Robert Y K
RY
Castiglia
Mary
M
Jeter
Barbara
B
Matthews
Julian C
JC
Chen
Kewei
K
Bandy
Dan
D
Reiman
Eric M
EM
Gold
Michael
M
Rabiner
Eugenii A
EA
Matthews
Paul M
PM